Date:2/7/2008

g or relating to our future financial results and guidance, statements regarding expectations and anticipated changes in product mix between business segments, statements regarding factors that will affect our cost of revenues and gross margins, statements regarding our beliefs about future demand, volumes and average prices for Grade I AP, our Fine Chemicals segment's order and operations levels, statements regarding our expectations for demand for sodium azide, statements regarding our expectations for Holotron volumes, statements relating to our expectations for revenue growth in our Aerospace Equipment segment, statements regarding our working capital changes and future variations, and all statements in the "Outlook" section of this earnings release. Words such as "anticipate", ""expect", "should", "may", "can", "will" and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by the Company that any of its expectations will be achieved. Actual results may differ materially from those set forth in the release due to risks and uncertainties inherent in the Company's business. Factors that might cause such differences include, but are not limited to, the following:

-- We depend on a limited number of customers for most of our sales in our

Specialty Chemicals, Aerospace Equipment and Fine Chemicals segments

and the loss of one or more of these customers could have a material

adverse affect on our revenues.

-- The inherent limitations of our fixed-price or similar contracts may

impact our profitability.

-- The numerous and often complex laws and regulations and regulatory

oversight to which our operations and properties are subject, the cost

of compliance, and the effect of any failure to comply could reduce our

profitability and liquidity.

-- A significant portion of o
'/>"/>

SOURCE American Pacific Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Related medicine news :

1. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
2. American Red Cross Responds to Tornadoes in the Southeast
3. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
4. Massive American Red Cross Tornado Relief Effort Spans Five States
5. Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns
6. Vitals.com Goes Red for American Heart Month
7. American Heart Month: Cracking Open Heart Health Myths
8. Consumer Reports Poll: Americans Demand Health Reform But Are Unsure About How to Achieve it
9. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
10. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
11. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP